ATX 3 314 0,3%  Dow 24 585 0,3%  Nasdaq 6 395 0,2%  Euro 1,1842 0,1% 
ATX P 1 674 0,2%  EStoxx50 3 566 -0,5%  Nikkei 22 694 -0,3%  CHF 1,1681 0,2% 
DAX 13 027 -0,8%  FTSE100 7 478 -0,3%  Öl 62,3 -0,8%  Gold 1 257 0,1% 

Neos Aktie [WKN DE: A0Q2HH / ISIN: JP3832370005]

02.11.2017 13:00:00

Neos Therapeutics to Host Third Quarter 2017 Financial Results Conference Call on November 8, 2017


DALLAS/FORT WORTH, Texas, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally disintegrating tablet (ODT) technology platforms, today announced that it will report its third quarter 2017 financial results prior to the opening of U.S. financial markets on Wednesday, November 8, 2017. Neos management will host a conference call and live audio webcast to discuss these results and provide a company update at 8:30 a.m. ET that same day.
Weiter zum vollständigen Artikel bei "Globe Newswire (RSS)"

Analysen zu Neos Corporation

mehr Analysen
  • Alle
  • Buy
  • Hold
  • Sell

Eintrag hinzufügen

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten
pagehit